Showing results (11-20 of 644) with videos related to
Sort By:
Pageof 65
Kardiologia Polska|February 5, 2023
PCSK9 inhibitors and reduction in cardiovascular events: Current evidence and future perspectivesStephen J NichollsEuropean Cardiology|October 13, 2018
Management of Severe Dyslipidaemia: Role of PCSK9 InhibitorsStephen J NichollsThe American Journal of Cardiology|November 10, 2009
High-density lipoprotein and progression rate of atherosclerosis in intravascular ultrasound trialsStephen J NichollsCurrent Opinion in Lipidology|September 23, 2017
Implications of GLAGOV studyStephen J Nicholls, Rishi PuriAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|December 20, 2018
Tackling Residual Atherosclerotic Risk in Statin-Treated Adults: Focus on Emerging DrugsKohei Takata, Stephen J NichollsDrugs of Today (Barcelona, Spain : 1998)|January 13, 2009
Atherosclerotic plaque reduction: blood pressure, dyslipidemia, atherothrombosisSatish Arora, Stephen J NichollsCurrent Medicinal Chemistry|June 22, 2006
Emerging role of intravascular ultrasound in the assessment of experimental anti-atherosclerotic therapiesStephen J Nicholls, Ilke SipahiCurrent Cardiology Reports|June 24, 2017
PCSK9 Inhibitors: Treating the Right Patients in Daily PracticePeta King, Stephen J NichollsCurrent Atherosclerosis Reports|April 29, 2010
Statin effects on both low-density lipoproteins and high-density lipoproteins: is there a dual benefit?Kiyoko Uno, Stephen J NichollsFuture Cardiology|September 26, 2015
Men and women--similar but not identical: insights into LDL-lowering therapy in women from the Cholesterol Treatment Trialists CollaborationLeonard Kritharides, Stephen J NichollsPageof 65